This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.Here is a sample of this item:Media Advisory - Oncolytics Biotech(R) Inc. to Present at BIO-Europe 2009 2009-11-02 07:30 ET - News Release CALGARY, Nov. 2 /CNW/ - Dr. Matt Coffey, Chief Operating Officer of Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY), will present a corporate overview of the Company at the BIO-Europe 2009 15th Annual International Partnering Conference on Wednesday, November 4, 2009. The event is being held at the Messe Wien Exhibition & Congress Center, Vienna, Austria from November 2-4, 2009. About the BIO-Europe Conference Bio-Europe is Europe's largest partnering conference, serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. Produced with the support of BIO, it is regarded as a "must attend" event for the biotech industry. About Oncolytics Biotech Inc. Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN(R), its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com. The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try,
click here for a free 30 day trial subscription. | 
Top
Print this Page